BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18505780)

  • 1. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
    Maciejewski JP; Mufti GJ
    Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
    Maciejewski JP; Tiu RV; O'Keefe C
    Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
    Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
    Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
    Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
    Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
    Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
    Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.
    Konialis C; Savola S; Karapanou S; Markaki A; Karabela M; Polychronopoulou S; Ampatzidou M; Voulgarelis M; Viniou NA; Variami E; Koumarianou A; Zoi K; Hagnefelt B; Schouten JP; Pangalos C
    Hematology; 2014 Jun; 19(4):217-24. PubMed ID: 23928116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates in cytogenetics and molecular markers in MDS.
    Tiu RV; Visconte V; Traina F; Schwandt A; Maciejewski JP
    Curr Hematol Malig Rep; 2011 Jun; 6(2):126-35. PubMed ID: 21340513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
    Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
    Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
    Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
    Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
    Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
    Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
    Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
    Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guiding the global evolution of cytogenetic testing for hematologic malignancies.
    Akkari YMN; Baughn LB; Dubuc AM; Smith AC; Mallo M; Dal Cin P; Diez Campelo M; Gallego MS; Granada Font I; Haase DT; Schlegelberger B; Slavutsky I; Mecucci C; Levine RL; Hasserjian RP; Solé F; Levy B; Xu X
    Blood; 2022 Apr; 139(15):2273-2284. PubMed ID: 35167654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
    Ahmad A; Iqbal MA
    Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaphase harvest and cytogenetic analysis of malignant hematological specimens.
    Dal Cin P; McLaughlin C
    Curr Protoc Hum Genet; 2012 Apr; Chapter 10():Unit 10.2.1-15. PubMed ID: 22470141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of clonal evolution in hematopoietic malignancies by combining comparative genomic hybridization and single nucleotide polymorphism arrays.
    Hartmann L; Stephenson CF; Verkamp SR; Johnson KR; Burnworth B; Hammock K; Brodersen LE; de Baca ME; Wells DA; Loken MR; Zehentner BK
    Clin Chem; 2014 Dec; 60(12):1558-68. PubMed ID: 25320376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide arrays in routine diagnostics of hematological malignancies.
    Simons A; Sikkema-Raddatz B; de Leeuw N; Konrad NC; Hastings RJ; Schoumans J
    Hum Mutat; 2012 Jun; 33(6):941-8. PubMed ID: 22488943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
    Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
    Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects.
    Hussein IR; Bader RS; Chaudhary AG; Bassiouni R; Alquaiti M; Ashgan F; Schulten HJ; Al Qahtani MH
    Pediatr Cardiol; 2018 Jun; 39(5):924-940. PubMed ID: 29541814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
    Tansatit M
    Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.